B. Björkstrand

2.2k total citations · 1 hit paper
16 papers, 1.7k citations indexed

About

B. Björkstrand is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, B. Björkstrand has authored 16 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in B. Björkstrand's work include Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Neutropenia and Cancer Infections (3 papers). B. Björkstrand is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Neutropenia and Cancer Infections (3 papers). B. Björkstrand collaborates with scholars based in Sweden, United Kingdom and Netherlands. B. Björkstrand's co-authors include Jane F. Apperley, Diana Samson, Sergio Giralt, Gösta Gahrton, Morie A. Gertz, Donna Reece, Joan Bladé, David H. Vesole, Per Ljungman and Gösta Gahrton and has published in prestigious journals such as Blood, Clinical Infectious Diseases and Annals of Oncology.

In The Last Decade

B. Björkstrand

16 papers receiving 1.6k citations

Hit Papers

CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION ... 1998 2026 2007 2016 1998 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
    1998 1.2k citations Joan Bladé, Diana Samson et al. British Journal of Haematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Björkstrand Sweden 13 1.4k 955 763 214 137 16 1.7k
David H. Vesole United States 21 1.5k 1.0× 1.2k 1.2× 819 1.1× 206 1.0× 270 2.0× 53 2.0k
Kimberly J. Henderson United States 13 1.0k 0.7× 955 1.0× 531 0.7× 221 1.0× 84 0.6× 18 1.3k
J A Katzmann United States 19 764 0.5× 627 0.7× 407 0.5× 194 0.9× 93 0.7× 28 1.2k
Gaëlle Guillerm France 18 1.4k 0.9× 768 0.8× 589 0.8× 527 2.5× 101 0.7× 66 1.8k
Cecilie Blimark Sweden 15 1.1k 0.8× 553 0.6× 530 0.7× 388 1.8× 187 1.4× 39 1.5k
Matthew Streetly United Kingdom 17 799 0.6× 586 0.6× 523 0.7× 137 0.6× 213 1.6× 52 1.2k
Huw Roddie United Kingdom 16 865 0.6× 605 0.6× 787 1.0× 101 0.5× 119 0.9× 29 1.4k
Naoki Takezako Japan 21 1.2k 0.8× 734 0.8× 843 1.1× 315 1.5× 356 2.6× 104 1.8k
Cyrille Hulin France 23 3.0k 2.1× 2.3k 2.5× 1.7k 2.2× 298 1.4× 113 0.8× 56 3.2k
Agapi Parcharidou Greece 13 782 0.5× 450 0.5× 242 0.3× 199 0.9× 160 1.2× 20 1.0k

Countries citing papers authored by B. Björkstrand

Since Specialization
Citations

This map shows the geographic impact of B. Björkstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Björkstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Björkstrand more than expected).

Fields of papers citing papers by B. Björkstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Björkstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Björkstrand. The network helps show where B. Björkstrand may publish in the future.

Co-authorship network of co-authors of B. Björkstrand

This figure shows the co-authorship network connecting the top 25 collaborators of B. Björkstrand. A scholar is included among the top collaborators of B. Björkstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Björkstrand. B. Björkstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Iacobelli, Stefano, Anja van Biezen, Christopher M. Morris, et al.. (2010). Primary plasma cell leukemia and autologous stem cell transplantation. Haematologica. 95(5). 804–809. 63 indexed citations
2.
Iacobelli, Stefano, Ute Hegenbart, Astrid Gruber, et al.. (2008). Autologous stem cell transplantation (ASCT) vs ASCT followed by reduced-intensity conditioning allogeneic SCT with identical sibling donor in previously untreated multiple myeloma: preliminary analysis of a prospective controlled trial by the EBMT. Bone Marrow Transplantation. 41. 1 indexed citations
3.
Gahrton, Gösta, Giuseppe Bandini, B. Björkstrand, et al.. (2007). Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica. 92(11). 1513–1518. 24 indexed citations
4.
5.
Kimby, Eva, et al.. (2001). High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILD. Leukemia Research. 25(3). 267–270. 12 indexed citations
6.
Pauksen, Karlis, et al.. (1998). Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients. Bone Marrow Transplantation. 22(1). 67–71. 34 indexed citations
7.
Larsson, Kjerstin, B. Björkstrand, & Per Ljungman. (1998). Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation. Supportive Care in Cancer. 6(4). 378–383. 15 indexed citations
8.
Bladé, Joan, Diana Samson, Donna Reece, et al.. (1998). CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION. British Journal of Haematology. 102(5). 1115–1123. 1187 indexed citations breakdown →
9.
Ljungman, Per, H Hägglund, B. Björkstrand, B Lönnqvist, & Olle Ringdén. (1997). Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Supportive Care in Cancer. 5(6). 485–488. 43 indexed citations
10.
Ljungman, Per, Jan Andersson, J Aschan, et al.. (1996). Oral Ribavirin for Prevention of Severe Liver Disease Caused by Hepatitis C Virus During Allogeneic Bone Marrow Transplantation. Clinical Infectious Diseases. 23(1). 167–169. 21 indexed citations
11.
Björkstrand, B.. (1996). Multiple myeloma, high-dose treatment and autologous stem cell transplantation—current status. Medical Oncology. 13(1). 23–30. 6 indexed citations
12.
Dilber, M. Siraç, B. Björkstrand, Birger Christensson, et al.. (1996). Suicide gene therapy for plasma cell tumors. Blood. 88(6). 2192–2200. 53 indexed citations
13.
Björkstrand, B., A. H. Goldstone, Per Ljungman, et al.. (1994). Prognostic Factors in Autologous Stem Cell Transplantation for Multiple Myeloma: An EBMT Registry Study. Leukemia & lymphoma. 15(3-4). 265–272. 43 indexed citations
14.
Björkstrand, B., et al.. (1994). Salivary and serum immunoglobulins in recipients of transplanted allogeneic and autologous bone marrow.. PubMed. 14(2). 229–34. 10 indexed citations
15.
Schouten, Harry C., P Colombat, Leo F. Verdonck, et al.. (1994). Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: The European Bone Marrow Transplant Group experience. Annals of Oncology. 5. S147–S149. 38 indexed citations
16.
Gorin, Norbert Claude, Myriam Labopin, Giovanna Meloni, et al.. (1991). Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).. PubMed. 5(10). 896–904. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David H. Vesole Breakdown of academic impact, for papers by Kimberly J. Henderson Breakdown of academic impact, for papers by J A Katzmann Breakdown of academic impact, for papers by Gaëlle Guillerm Breakdown of academic impact, for papers by Cecilie Blimark Breakdown of academic impact, for papers by Matthew Streetly Breakdown of academic impact, for papers by Huw Roddie Breakdown of academic impact, for papers by Naoki Takezako Breakdown of academic impact, for papers by Cyrille Hulin Breakdown of academic impact, for papers by Agapi Parcharidou
Rankless by CCL
2026